A novel PET imaging strategy can successfully quantify a key enzyme related to mind irritation, in line with analysis published within the March concern of The Journal of Nuclear Medicine. The first-in-human study, which imaged the COX-2 enzyme, gives a never-before-seen view of irritation within the mind, opening the door for COX-2 PET imaging for use in medical and analysis settings for numerous mind problems.
COX-2 is an enzyme within the mind that may be markedly upregulated by inflammatory stimuli and neuroexcitation. Researchers say that the density of COX-2 within the mind could also be a biomarker and impact of irritation, even when it’s not a mediator of the inflammatory course of.
“While COX-2 has been broadly studied in peripheral irritation, its function in neuroinflammation has been troublesome to quantify in vivo,” acknowledged Robert B. Innis, MD, PhD, senior investigator within the Molecular Imaging Branch of the National Institute of Mental Health on the National Institutes of Health in Bethesda, Maryland. “We sought to ascertain a non-invasive imaging technique to measure COX-2 within the dwelling mind to allow earlier illness detection, monitor illness development, and assess anti-inflammatory remedies.”
This study evaluated the flexibility of 11C-MC1 to measure COX-2 ranges within the wholesome human mind. First, 11C-MC1’s affinity for human COX-2 was assessed by conducting PET imaging in rats injected with lipopolysaccharide and in humanized transgenic COX-2 mice. Specific binding to human COX-2 was confirmed. Subsequently, 27 wholesome human volunteers have been imaged with 11C-MC1 PET to quantify the density of COX-2 within the human mind.
Among study members, 11C-MC1 effectively crossed the blood–mind barrier, certain to its designated goal, and demonstrated excessive specificity for human COX-2. The radiotracer additionally had a reasonable ratio of particular to background uptake binding potential in cortical areas.
“Neuroinflammation performs a crucial function in lots of neurological and psychiatric illnesses, together with Alzheimer’s illness, Parkinson’s illness, and main depressive dysfunction,” famous Innis.
“This may very well be a game-changer for personalised medication and therapeutic improvement. It additionally demonstrates the potential for growing different PET tracers to analyze neuroinflammation, broadening the purposes of nuclear medication in neurology and psychiatry.”
More data:
Xuefeng Yan et al, PET Quantification in Healthy Humans of Cyclooxygenase-2, a Potential Biomarker of Neuroinflammation, Journal of Nuclear Medicine (2025). DOI: 10.2967/jnumed.124.268525
Provided by
Society of Nuclear Medicine and Molecular Imaging
Citation:
New PET radiotracer supplies first have a look at irritation biomarker in human mind (2025, March 28)
29
pet-radiotracer-inflammation-biomarker-human.html
.
. The content material is supplied for data functions solely.